DAFNA Capital Management as of March 31, 2025
Portfolio Holdings for DAFNA Capital Management
DAFNA Capital Management holds 83 positions in its portfolio as reported in the March 2025 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Spdr S&p Biotech Etf Etf (XBI) | 9.3 | $33M | 405k | 81.10 | |
| Stereotaxis Com New (STXS) | 6.8 | $24M | 14M | 1.76 | |
| Revolution Medicines (RVMD) | 6.6 | $23M | 656k | 35.36 | |
| Merus N V (MRUS) | 5.5 | $19M | 462k | 42.09 | |
| AtriCure (ATRC) | 5.4 | $19M | 592k | 32.26 | |
| Cytokinetics Com New (CYTK) | 4.5 | $16M | 398k | 40.19 | |
| Blueprint Medicines (BPMC) | 3.8 | $14M | 152k | 88.51 | |
| Ishares Nasdaq Biotech Indx Etf (IBB) | 3.7 | $13M | 103k | 127.90 | |
| Axogen (AXGN) | 3.6 | $13M | 681k | 18.50 | |
| Ascendis Pharma A/s Sponsored Adr (ASND) | 3.6 | $13M | 80k | 155.86 | |
| Ideaya Biosciences (IDYA) | 2.7 | $9.7M | 589k | 16.38 | |
| Xenon Pharmaceuticals (XENE) | 2.6 | $9.2M | 274k | 33.55 | |
| Kalvista Pharmaceuticals (KALV) | 2.5 | $8.7M | 752k | 11.54 | |
| Neurocrine Biosciences (NBIX) | 2.2 | $7.9M | 72k | 110.60 | |
| Syndax Pharmaceuticals (SNDX) | 1.9 | $6.7M | 545k | 12.29 | |
| Day One Biopharmaceuticals I (DAWN) | 1.6 | $5.8M | 731k | 7.93 | |
| Tandem Diabetes Care Com New (TNDM) | 1.6 | $5.6M | 294k | 19.16 | |
| Urogen Pharma (URGN) | 1.5 | $5.4M | 493k | 11.06 | |
| Biohaven (BHVN) | 1.5 | $5.3M | 220k | 24.04 | |
| Mineralys Therapeutics (MLYS) | 1.4 | $4.9M | 309k | 15.88 | |
| Arcus Biosciences Incorporated (RCUS) | 1.4 | $4.9M | 625k | 7.85 | |
| Ascendis Pharma A/s Note 2.250% 4/0 (Principal) | 1.3 | $4.7M | 4.0M | 1.18 | |
| Dex (DXCM) | 1.3 | $4.5M | 66k | 68.29 | |
| BioCryst Pharmaceuticals (BCRX) | 1.2 | $4.2M | 558k | 7.50 | |
| Edgewise Therapeutics (EWTX) | 1.1 | $4.0M | 183k | 22.00 | |
| Galapagos Nv Spon Adr (GLPG) | 0.9 | $3.3M | 130k | 25.12 | |
| Inogen (INGN) | 0.9 | $3.3M | 458k | 7.13 | |
| Insulet Corporation (PODD) | 0.9 | $3.1M | 12k | 262.61 | |
| Alkermes SHS (ALKS) | 0.9 | $3.1M | 94k | 33.02 | |
| Kura Oncology (KURA) | 0.9 | $3.1M | 463k | 6.60 | |
| Stoke Therapeutics (STOK) | 0.8 | $3.0M | 444k | 6.65 | |
| Immunovant (IMVT) | 0.8 | $2.9M | 170k | 17.09 | |
| Bicara Therapeutics (BCAX) | 0.8 | $2.8M | 212k | 13.03 | |
| Accuray Incorporated (ARAY) | 0.6 | $2.2M | 1.2M | 1.79 | |
| 2seventy Bio Common Stock | 0.6 | $2.1M | 429k | 4.94 | |
| Proqr Therapeutics N V Shs Euro (PRQR) | 0.6 | $2.1M | 1.6M | 1.33 | |
| Compass Pathways Sponsored Ads (CMPS) | 0.6 | $2.0M | 711k | 2.86 | |
| Allogene Therapeutics (ALLO) | 0.6 | $2.0M | 1.4M | 1.46 | |
| Tela Bio (TELA) | 0.5 | $1.8M | 1.4M | 1.22 | |
| Align Technology (ALGN) | 0.5 | $1.7M | 11k | 158.86 | |
| Denali Therapeutics (DNLI) | 0.5 | $1.7M | 128k | 13.60 | |
| Astria Therapeutics | 0.5 | $1.7M | 315k | 5.34 | |
| Viking Therapeutics (VKTX) | 0.4 | $1.6M | 65k | 24.15 | |
| Regulus Therapeutics | 0.4 | $1.5M | 847k | 1.75 | |
| Brainsway Sponsored Ads (BWAY) | 0.4 | $1.5M | 157k | 9.47 | |
| Oric Pharmaceuticals (ORIC) | 0.4 | $1.4M | 242k | 5.58 | |
| Keros Therapeutics (KROS) | 0.4 | $1.3M | 130k | 10.19 | |
| Lexeo Therapeutics (LXEO) | 0.4 | $1.3M | 378k | 3.47 | |
| Iteos Therapeutics | 0.4 | $1.3M | 213k | 5.97 | |
| Palvella Therapeutics Inc Ne (PVLA) | 0.3 | $1.2M | 43k | 27.99 | |
| Silverback Therapeutics (SPRY) | 0.3 | $1.2M | 95k | 12.58 | |
| Lineage Cell Therapeutics In (LCTX) | 0.3 | $1.1M | 2.5M | 0.45 | |
| Alector (ALEC) | 0.3 | $1.1M | 913k | 1.23 | |
| Foghorn Therapeutics (FHTX) | 0.3 | $1.1M | 305k | 3.65 | |
| Immatics Nv SHS (IMTX) | 0.3 | $1.1M | 245k | 4.51 | |
| Structure Therapeutics Sponsored Ads (GPCR) | 0.3 | $1.0M | 59k | 17.31 | |
| Vyne Therapeutics (VYNE) | 0.3 | $1.0M | 636k | 1.58 | |
| Mediwound Shs New (MDWD) | 0.3 | $1.0M | 65k | 15.52 | |
| Gossamer Bio (GOSS) | 0.3 | $999k | 908k | 1.10 | |
| Biontech Se Sponsored Ads (BNTX) | 0.3 | $956k | 11k | 91.06 | |
| Autolus Therapeutics Spon Ads (AUTL) | 0.3 | $909k | 587k | 1.55 | |
| Sage Therapeutics (SAGE) | 0.2 | $860k | 108k | 7.95 | |
| Korro Bio (KRRO) | 0.2 | $820k | 47k | 17.41 | |
| Century Therapeutics (IPSC) | 0.2 | $811k | 1.7M | 0.48 | |
| Larimar Therapeutics (LRMR) | 0.2 | $799k | 371k | 2.15 | |
| Polypid (PYPD) | 0.2 | $789k | 291k | 2.71 | |
| Taysha Gene Therapies Com Shs (TSHA) | 0.2 | $726k | 523k | 1.39 | |
| Bicycle Therapeutics Sponsored Ads (BCYC) | 0.2 | $686k | 81k | 8.49 | |
| Neurogene (NGNE) | 0.2 | $603k | 52k | 11.71 | |
| Cardiff Oncology (CRDF) | 0.1 | $471k | 150k | 3.14 | |
| Erasca (ERAS) | 0.1 | $466k | 340k | 1.37 | |
| Inflarx Nv (IFRX) | 0.1 | $459k | 450k | 1.02 | |
| Adicet Bio | 0.1 | $453k | 600k | 0.76 | |
| Aquestive Therapeutics (AQST) | 0.1 | $412k | 142k | 2.90 | |
| Compugen Ord (CGEN) | 0.1 | $398k | 272k | 1.46 | |
| Adc Therapeutics Sa SHS (ADCT) | 0.1 | $316k | 224k | 1.41 | |
| Sutro Biopharma | 0.1 | $284k | 437k | 0.65 | |
| Aprea Therapeutics Com New (APRE) | 0.1 | $280k | 137k | 2.04 | |
| Biomx Com New | 0.1 | $223k | 401k | 0.56 | |
| Nevro (NVRO) | 0.1 | $222k | 38k | 5.84 | |
| Black Diamond Therapeutics (BDTX) | 0.1 | $217k | 140k | 1.55 | |
| Spero Therapeutics (SPRO) | 0.0 | $90k | 125k | 0.72 | |
| Tenaya Therapeutics (TNYA) | 0.0 | $27k | 47k | 0.57 |
